Archaea from the gut microbiota of humans: Could be linked to chronic diseases?

Humans Archaea / genetics Gastrointestinal Microbiome Methanobrevibacter / genetics Euryarchaeota Methane Chronic Disease
Archaea Cardiovascular disease Chronic kidney disease Gut microbiota Methane

Journal

Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 03 03 2022
revised: 31 07 2022
accepted: 11 08 2022
pubmed: 20 8 2022
medline: 2 11 2022
entrez: 19 8 2022
Statut: ppublish

Résumé

Archaea comprise a unique domain of organisms with distinct biochemical and genetic differences from bacteria. Methane-forming archaea, methanogens, constitute the predominant group of archaea in the human gut microbiota, with Methanobrevibacter smithii being the most prevalent. However, the effect of methanogenic archaea and their methane production on chronic disease remains controversial. As perturbation of the microbiota is a feature of chronic conditions, such as cardiovascular disease, neurodegenerative diseases and chronic kidney disease, assessing the influence of archaea could provide a new clue to mitigating adverse effects associated with dysbiosis. In this review, we will discuss the putative role of archaea in the gut microbiota in humans and the possible link to chronic diseases.

Identifiants

DOI: 10.1016/j.anaerobe.2022.102629 PMID: 35985606
pubmed: 35985606
pii: S1075-9964(22)00122-6
doi: 10.1016/j.anaerobe.2022.102629
pii:
doi:

Substances chimiques

Methane OP0UW79H66

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102629

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflicts of interest.

Auteurs

Denise Mafra (D)

Graduate Program in Biological Sciences - Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, (RJ), Brazil; Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói, Brazil; Graduate Program in Medical Sciences, Fluminense Federal University (UFF), Niterói, Brazil. Electronic address: dm@id.uff.br.

Marcia Ribeiro (M)

Graduate Program in Biological Sciences - Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, (RJ), Brazil.

Larissa Fonseca (L)

Graduate Program in Medical Sciences, Fluminense Federal University (UFF), Niterói, Brazil.

Bruna Regis (B)

Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói, Brazil.

Ludmila F M F Cardozo (LFMF)

Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói, Brazil.

Henrique Fragoso Dos Santos (H)

Department of Marine Biology, Fluminense Federal University (UFF), Niterói, RJ, Brazil.

Hugo Emiliano de Jesus (H)

Department of Marine Biology, Fluminense Federal University (UFF), Niterói, RJ, Brazil.

Junia Schultz (J)

Microbial Ecogenomics and Biotechnology Laboratory, Biological and Environmental Science and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Makkah, 23955, Saudi Arabia.

Paul G Shiels (PG)

Wolfson Wohl Translational Research Centre, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1QH, UK.

Peter Stenvinkel (P)

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden.

Alexandre Rosado (A)

Microbial Ecogenomics and Biotechnology Laboratory, Biological and Environmental Science and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Makkah, 23955, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Archaea from the gut microbiota of humans:...
questionsmedicales.fr › Archéobactéries › Archaea from the gut microbiota of humans:...
questionsmedicales.fr › Environnement et santé publique › Environnement › Écosystème › Biodiversité › Biote › Microbiote › Microbiome gastro-intestinal › Archaea from the gut microbiota of humans:...
questionsmedicales.fr › Archéobactéries › Euryarchaeota › Methanobacteriales › Methanobacteriaceae › Methanobrevibacter › Archaea from the gut microbiota of humans:...
questionsmedicales.fr › Archéobactéries › Euryarchaeota › Archaea from the gut microbiota of humans:...
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures acycliques › Alcanes › Méthane › Archaea from the gut microbiota of humans:...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Archaea from the gut microbiota of humans:...